Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional roles of glycogene and N‐glycan in multidrug resistance of human breast cancer cells

26 Feb 2013

Abstract excerpt

Drug resistance is a major problem in cancer chemotherapy. Aberrant glycosylation has been known to be associated with cancer chemoresistance. Aim of this work is to investigate the alterations of glycogene and N-glycan involved in multidrug resistance (MDR) in human breast cancer cell lines. Using real-time polymerase chain reaction (PCR) for quantification of glycogenes, fluorescein isothiocyanate (FITC)-lectin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbohydrate Chemistry and Synthesis
Share to Drug Transport and Resistance Mechanisms
Share to Glycosylation and Glycoproteins Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23441047
DOI: 10.1002/iub.1133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional roles of glycogene and N‐glycan in multidrug resistance of human breast cancer cellsPMID 23441047Read ↗

Breast cancer N Glycosylation dysregulation driven by mutations modulates chemotherapy response and macrophage immunosuppressionSemantic proximity Read ↗

GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer CellsSemantic proximity Read ↗

Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapySemantic proximity Read ↗

Cell Surface-Specific N-Glycan Profiling in Breast CancerSemantic proximity Read ↗

Dynamic analysis of N-glycomic and transcriptomic changes in the development of ovarian cancer cell line A2780 to its three cisplatin-resistant variantsSemantic proximity Read ↗

Clinical relevance of glycosylation in triple negative breast cancer: a reviewSemantic proximity Read ↗

Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.Semantic proximity Read ↗

Glycomic alterations are associated with multidrug resistance in human leukemiaSemantic proximity Read ↗

Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins.Semantic proximity Read ↗

Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylationSemantic proximity Read ↗

Bisecting N-Acetylglucosamine Structures Inhibit Hypoxia-Induced Epithelial-Mesenchymal Transition in Breast Cancer CellsSemantic proximity Read ↗

Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.